Kyriaki Michailidou - Genetic Mutations

Author Information

Kyriaki Michailidou is affiliated with the Department of Electron Microscopy/Molecular Pathology at The Cyprus Institute of Neurology and Genetics, located in Nicosia, Cyprus. This affiliation underscores her active involvement in cutting-edge research within the field of genetics, particularly focusing on molecular pathology.

Research Contributions

Kyriaki Michailidou has made significant contributions in the field of genetics, with a particular focus on breast cancer research and genetic studies related to hemoglobinopathies. In 2022, she co-authored several studies, including genome-wide association analyses that identified novel breast cancer susceptibility loci and explored gene-environment interactions affecting breast cancer risk. Her research also extends to genetic modifiers in hemoglobinopathies, as evidenced by her involvement with the International Hemoglobinopathy Research Network (INHERENT). Additionally, Michailidou's work on genetic variants and their impact on distinct tumor subtypes and mammographic density phenotypes highlights her comprehensive approach to understanding complex genetic interactions.

Aliases

Throughout her academic career, Kyriaki Michailidou has been referenced under several aliases, including K Michailidou, K. Michailidou, and Kyriaki Michailidou. These variations reflect the common practice of using different name formats in scholarly publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	14,614
H-index	60
Total Paper Count	249

Publications:

Correction: Comparative Y-chromosome analysis among Cypriots in the context of historical events and migrations

DOI: 10.1371/journal.pone.0267875

Year: 2022

A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

DOI: 10.3390/cancers14051206

Year: 2022

A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women

DOI: 10.1158/2767-9764.crc-21-0119

Year: 2022

Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women

DOI: 10.1038/s41598-022-10121-2

Year: 2022

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

DOI: 10.1186/s13058-022-01524-0

Year: 2022

Rare germline copy number variants (CNVs) and breast cancer risk

DOI: 10.1038/s42003-021-02990-6

Year: 2022

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

DOI: 10.1186/s13058-021-01484-x

Year: 2022

P117: THE INTERNATIONAL HAEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATIVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HAEMOGLOBINOPATHIES

DOI: 10.1097/01.HS9.0000821560.98552.2f

Year: 2022

The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies

DOI: 10.1002/ajh.26323

Year: 2021

Implementation of multigene panel NGS diagnosis in the national primary ciliary dyskinesia cohort of Cyprus: An island with a high disease prevalence

DOI: 10.1002/humu.24196

Year: 2021

What Is the Future of Research in Brain Development and Genetics?

What is Polymerase Chain Reaction (PCR)?

How Does Phylogenetic Analysis Relate to Genetic Mutations?

What is the Link Between Tobacco Mutagens and Cancer?

How Do Genetic Mutations Influence ASD?

How Do Insertion Mutations Occur?

What is Mutation?

Can Mutations Be Treated or Reversed?

What Are the Causes of Transversions?

Can Genetic Disorders Affect Child Development?

Partnered Content Networks

Relevant Topics